Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. STKE, 10 April 2001
Vol. 2001, Issue 77, p. tw3
[DOI: 10.1126/stke.2001.77.tw3]


Development TGF-β Receptor Type I and Angiogenesis

Transforming growth factor-β (TGF-β)-deficient mice have greatly impaired vascular and hematopoietic development, but because TGF-β can signal through several heterodimeric receptors, it is not known whether defects in angiogenesis and hematopoiesis are mediated by the loss of specific receptor subunits. Larsson et al. created TGF-β type I receptor (TβRI)-deficient mice and found that yolk sacs from embryonic lethal mice had defective angiogenesis, leading to an impaired vasculature. Endothelial cells from TβRI-/- mice exhibited aberrant migration and defective fibronectin production in vitro, which correlated with the impaired vasculature in vivo. Hematopoiesis in TβRI-/- mice was normal, indicating that TβRI function is critical for proper angiogenesis but not for hematopoietic development.

J. Larsson, M.-J. Goumans, L. Jansson Sjöstrand, M. A. van Rooijen, D. Ward, P. Levéen, X. Xu, P. ten Dijke, C. L. Mummery, S. Karlsson, Abnormal angiogenesis but intact hematopoeitic potential in TGF-β type I receptor-deficient mice. EMBO J. 20, 1663-1673 (2001). [Abstract] [Full Text]

Citation: TGF-β Receptor Type I and Angiogenesis. Sci. STKE 2001, tw3 (2001).

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882